Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line
Lobna Gharaibeh, Walhan Alshaer, Suha Wehaibi, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 65, pp. 102733-102733
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Aptamer-Based Targeted Delivery of Functional Nucleic Acids
Sitao Xie, Weidi Sun, Ting Fu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 7677-7691
Closed Access | Times Cited: 63
A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy
Prashant Kesharwani, Afsana Sheikh, Mohammed A. S. Abourehab, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104164-104164
Closed Access | Times Cited: 45
Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation
Reem Qannita, Ayah Alalami, Amani A. Harb, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 195-195
Open Access | Times Cited: 39
Liposome-Based Drug Delivery Systems in Cancer Research: An Analysis of Global Landscape Efforts and Achievements
Islam Hamad, Amani A. Harb, Yasser Bustanji
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 400-400
Open Access | Times Cited: 19
Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy
Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Larissa Bueno Tofani, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 821-821
Open Access | Times Cited: 48
Nano-formulated siRNA-based therapeutic approaches for cancer therapy
Dolly Jain, Shiv Kumar Prajapati, Ankit Jain, et al.
Nano Trends (2023) Vol. 1, pp. 100006-100006
Open Access | Times Cited: 26
Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine
Ibraheem Dakilah, Amani A. Harb, Eman Abu‐Gharbieh, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs
Hamed Manoochehri, Akram Jalali, Hamid Tanzadehpanah, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 218, pp. 112714-112714
Closed Access | Times Cited: 28
Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer
Yan Shan Loo, N. Idayu Zahid, Thiagarajan Madheswaran, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 71, pp. 103300-103300
Closed Access | Times Cited: 25
Gold nanoparticles and breast cancer: A bibliometric analysis of the current state of research and future directions
Yasser Bustanji, Jalal Taneera, Mohammad H. Semreen, et al.
OpenNano (2023) Vol. 12, pp. 100164-100164
Open Access | Times Cited: 15
Unlocking the Therapeutic Potential of BCL-2 Associated Protein Family: Exploring BCL-2 Inhibitors in Cancer Therapy
Bisan El Dakkak, Jalal Taneera, Waseem El‐Huneidi, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 267-280
Open Access | Times Cited: 5
New insights in aptamer-targeted nanoliposomes for the treatment of breast cancer
Nidhi Jain Singhai, Rahul Maheshwari, Kapil Khatri
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104880-104880
Closed Access | Times Cited: 13
Emerging trends in nano-carrier based gene delivery systems for targeted cancer therapy
Rohit Bhatia, Amandeep Singh, Sukhwinder Singh, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105546-105546
Closed Access | Times Cited: 4
Soybean Oil‐Derived Lipids for Efficient mRNA Delivery
Zhongmin Tang, Fan Yu, Jessica C. Hsu, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Open Access | Times Cited: 10
Advancements and global perspectives in the green synthesis of silver nanoparticles: A two-decade analysis
Islam Hamad, Shereen M. Aleidi, Walhan Alshaer, et al.
Pharmacia (2025) Vol. 72, pp. 1-13
Open Access
Review of recent preclinical and clinical research on ligand-targeted liposomes as delivery systems in triple negative breast cancer therapy
Mohammad Hajimolaali, Farid Abedin Dorkoosh, Sophia G. Antimisiaris
Journal of Liposome Research (2024) Vol. 34, Iss. 4, pp. 671-696
Closed Access | Times Cited: 3
Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer
Ujala Gupta, Brojendra Nath Saren, Kedar Khaparkhuntikar, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 1089-1115
Closed Access | Times Cited: 14
Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer
Pratibha Pandey, Fahad Khan, Min Gew Choi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114938-114938
Open Access | Times Cited: 7
TNA‐Mediated Antisense Strategy to Knockdown Akt Genes for Triple‐Negative Breast Cancer Therapy
Pan Li, Shixue Zheng, Hoi Man Leung, et al.
Small Methods (2024) Vol. 8, Iss. 11
Open Access | Times Cited: 2
Current Advances in Non-viral Nanoparticle-Based Gene Therapy for Effective Management of Cancer.
Anish Dhuri, Tanmoy Kanp, Khushi Rode, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106083-106083
Closed Access | Times Cited: 2
Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery
Hafsa Al-Azzawi, Walhan Alshaer, Ezaldeen Esawi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 69, pp. 103169-103169
Closed Access | Times Cited: 8
In vitro studies on curcumin-loaded multiwalled carbon nanotubes antioxidant activities and cytotoxicity against Hep G-2 liver cancer cell lines
Manar M. Rabba’a, Rund Abu‐Zurayk, Bashaer Abu‐Irmaileh, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access | Times Cited: 1
Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
Shinjit Mani, Abhishek Hande, Sergei Boichuk
BioNanoScience (2022) Vol. 12, Iss. 4, pp. 1404-1435
Closed Access | Times Cited: 4
G-Quadruplex-Based Aptamers in Therapeutic Applications
Domenica Musumeci, Daniela Montesarchio
(2023), pp. 1-26
Closed Access | Times Cited: 2
Transposition of polymer-encapsulated small interfering RNA through lung surfactant models at the air-water interface
Lucas Miguel Pereira Souza, Mariana Camacho Lima, Luiz Filipe Silva Bezerra, et al.
Chemical Physics (2022) Vol. 563, pp. 111704-111704
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top